Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
7.35
+0.46 (6.76%)
Oct 2, 2025, 3:45 PM EDT - Market open
DAWN Market Cap
DAWN has a market cap or net worth of $752.36 million as of October 2, 2025. Its market cap has decreased by -44.71% in one year.
Market Cap
752.36M
Enterprise Value
249.51M
1-Year Change
-44.71%
Ranking
Category
Stock Price
$7.35
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has decreased from $965.40M to $752.36M, a decrease of -22.07%. That is a compound annual growth rate of -5.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 704.73M | -44.84% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.97B |
| Johnson & Johnson | 446.55B |
| AbbVie | 409.03B |
| UnitedHealth Group | 312.73B |
| Novartis AG | 243.07B |
| Novo Nordisk | 240.58B |
| Abbott Laboratories | 233.12B |
| AstraZeneca | 233.08B |